个人中心 - 老虎社区

CEXL83

IP属地：未知

帖子 · 17帖子 · 17
关注 · 0关注 · 0
粉丝 · 0粉丝 · 0

- CEXL83CEXL83
  ·2021-11-04
  $iRobot(IRBT)$Will it move beyond $105?
  1,156 评论
  点赞
  分享
  举报
- CEXL83CEXL83
  ·2021-08-01
  Hope for the best in Aug
  非常抱歉，此主贴已删除
  581 2
  8
  分享
  举报
- CEXL83CEXL83
  ·2021-08-01
  On no…
  Investors, Beware! Stocks Are Entering the Most Dangerous Stretch of the Year
  “Yes, it’s summer, my time of year,”as the group War sangin that golden oldie “Summer” from the 1970
  Investors, Beware! Stocks Are Entering the Most Dangerous Stretch of the Year
  661 评论
  2
  分享
  举报
- CEXL83CEXL83
  ·2021-07-31
  Hopefully next month will be a better month for all of us!
  非常抱歉，此主贴已删除
  493 1
  8
  分享
  举报
- CEXL83CEXL83
  ·2021-06-18
  Like
  非常抱歉，此主贴已删除
  946 评论
  1
  分享
  举报
- CEXL83CEXL83
  ·2021-06-18
  Ok
  非常抱歉，此主贴已删除
  652 评论
  点赞
  分享
  举报
- CEXL83CEXL83
  ·2021-06-18
  Can buy?
  Column: The FDA's hasty approval of a new Alzheimer's drug is looking worse than ever
  The FDA's decision on Aduhelm sets up a healthcare spending crisis. Following a year in which the F
  Column: The FDA's hasty approval of a new Alzheimer's drug is looking worse than ever
  856 1
  点赞
  分享
  举报
- CEXL83CEXL83
  ·2021-06-18
  Up
  Why Bankers Just Complicated El Salvador’s Bitcoin Plan
  The price ofBitcoin(CCC:BTC-USD) slipped to below $39,000 on Thursday after the World Bank refused E
  Why Bankers Just Complicated El Salvador’s Bitcoin Plan
  1,354 评论
  点赞
  分享
  举报
- CEXL83CEXL83
  ·2021-06-18
  Can buy?
  RUN Stock: Why Morgan Stanley Thinks Sunrun Is the ‘Most Compelling’ Clean Energy Stock
  Sunrun(NASDAQ:RUN) stock is running higher on Thursday following a positive report on the company fr
  RUN Stock: Why Morgan Stanley Thinks Sunrun Is the ‘Most Compelling’ Clean Energy Stock
  1,181 评论
  点赞
  分享
  举报
- CEXL83CEXL83
  ·2021-06-18
  Up
  Why Bankers Just Complicated El Salvador’s Bitcoin Plan
  The price ofBitcoin(CCC:BTC-USD) slipped to below $39,000 on Thursday after the World Bank refused E
  Why Bankers Just Complicated El Salvador’s Bitcoin Plan
  729 评论
  点赞
  分享
  举报

热议股票

{"i18n":{"language":"zh_CN"},"isCurrentUser":false,"userPageInfo":{"id":"3581937708618440","uuid":"3581937708618440","gmtCreate":1618854046616,"gmtModify":1618885030432,"name":"CEXL83","pinyin":"cexl83","introduction":"","introductionEn":null,"signature":"","avatar":"https://static.tigerbbs.com/9f2c9405fa013dc6a212860bb07a6d46","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":2,"headSize":8,"tweetSize":17,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":1,"name":"萌萌虎","nameTw":"萌萌虎","represent":"呱呱坠地","factor":"评论帖子3次或发布1条主帖（非转发）","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":null,"userBadges":[{"badgeId":"e50ce593bb40487ebfb542ca54f6a561-1","templateUuid":"e50ce593bb40487ebfb542ca54f6a561","name":"出道虎友","description":"加入老虎社区500天","bigImgUrl":"https://static.tigerbbs.com/0e4d0ca1da0456dc7894c946d44bf9ab","smallImgUrl":"https://static.tigerbbs.com/0f2f65e8ce4cfaae8db2bea9b127f58b","grayImgUrl":"https://static.tigerbbs.com/c5948a31b6edf154422335b265235809","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2022.09.17","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"518b5610c3e8410da5cfad115e4b0f5a-1","templateUuid":"518b5610c3e8410da5cfad115e4b0f5a","name":"实盘交易者","description":"完成一笔实盘交易","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":2,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":2,"crmLevelSwitch":0,"location":"未知","starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"page":1,"watchlist":null,"tweetList":[{"id":846984837,"gmtCreate":1636039790411,"gmtModify":1636039790547,"author":{"id":"3581937708618440","authorId":"3581937708618440","name":"CEXL83","avatar":"https://static.tigerbbs.com/9f2c9405fa013dc6a212860bb07a6d46","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3581937708618440","authorIdStr":"3581937708618440"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/IRBT\">$iRobot(IRBT)$</a>Will it move beyond $105?","listText":"<a href=\"https://laohu8.com/S/IRBT\">$iRobot(IRBT)$</a>Will it move beyond $105?","text":"$iRobot(IRBT)$Will it move beyond $105?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/846984837","isVote":1,"tweetType":1,"viewCount":1156,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":802737961,"gmtCreate":1627805563453,"gmtModify":1631884320075,"author":{"id":"3581937708618440","authorId":"3581937708618440","name":"CEXL83","avatar":"https://static.tigerbbs.com/9f2c9405fa013dc6a212860bb07a6d46","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3581937708618440","authorIdStr":"3581937708618440"},"themes":[],"htmlText":"Hope for the best in Aug","listText":"Hope for the best in Aug","text":"Hope for the best in Aug","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":8,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/802737961","repostId":"2155001152","repostType":4,"isVote":1,"tweetType":1,"viewCount":581,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":802734840,"gmtCreate":1627805463380,"gmtModify":1633756217585,"author":{"id":"3581937708618440","authorId":"3581937708618440","name":"CEXL83","avatar":"https://static.tigerbbs.com/9f2c9405fa013dc6a212860bb07a6d46","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3581937708618440","authorIdStr":"3581937708618440"},"themes":[],"htmlText":"On no…","listText":"On no…","text":"On no…","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/802734840","repostId":"1142925544","repostType":4,"repost":{"id":"1142925544","kind":"news","pubTimestamp":1627787240,"share":"https://ttm.financial/m/news/1142925544?lang=&edition=full","pubTime":"2021-08-01 11:07","market":"us","language":"en","title":"Investors, Beware! Stocks Are Entering the Most Dangerous Stretch of the Year","url":"https://stock-news.laohu8.com/highlight/detail?id=1142925544","media":"Barron's","summary":"“Yes, it’s summer, my time of year,”as the group War sangin that golden oldie “Summer” from the 1970","content":"<p>“Yes, it’s summer, my time of year,”as the group War sangin that golden oldie “Summer” from the 1970s, recalling pleasant times at the beach or by the barbecue. No need to remind anyone back then of droughts, wildfires, or Covid-19 surges that are unfortunate features of the steamy season this year.</p>\n<p>But the coming of August also means entering what historically has been the most treacherous stretch of the year for stocks, according to data going back to 1928 compiled by Bank of America analyst Stephen Suttmeier. He finds that theS&amp;P 500index had a negative return averaging 0.03% in August, September, and October—the worst three-month span of the year for the big-cap benchmark. In fact, they constitute the only three-month period that averages in the red.</p>\n<p>August actually is bracketed by the best and worst months of the year, he adds in a research note. July averages a 1.58% return on the S&amp;P 500, with positive results 59.1% of the time, while September averages a negative 1.03%, ending in the plus column less than half of the time, or 45%.</p>\n<p>This July did even better than the norm, with the S&amp;P 500 gaining 2.27%. It also was the sixth consecutive up month for the index—the longest positive streak since September 2018, according to Dow Jones’ statistical mavens. During that period, its cumulative advance was 18.34%.</p>\n<p>August’s record is in between, with an average 0.70% S&amp;P 500 return and positive results 58.1% of the time, marking a transition from the “summer rip” to the “fall dip.”</p>\n<p>Not surprisingly, the laggard returns of the August-October period are accompanied by an uptick in volatility, Suttmeier finds. Based on records going back to 1992, theCboe Volatility Index,or VIX, has often seen spikes during those months, following relatively subdued volatility in the April-July period.</p>\n<p>Past isn’t necessarily prologue, but if it is, the timing of the initial public offering byRobinhood Markets(ticker: HOOD) might prove propitious, if the stock market does have its typical seasonal rough patch. The online broker, whose putative mission is to open investing to novices supposedly ignored by established outfits, sold 55 million shares at $38 on Thursday. In the process, it provided a valuable lesson to all those who got in on the IPO: Buy low and sell high.</p>\n<p>The company evidently fulfilled the latter imperative, selling its shares high, even though they were priced at the low end of the expected $38-$42 range. Their price sank 8.4% on their first day of trading, although they recouped a bit on Friday. By week’s end, buyers of Robinhood’s IPO who held were down 7.5%.</p>\n<p>Among those who sold high were the company’s co-founders, CEO Vladimir Tenev and Chief Creative Officer Baiju Bhatt, who each offloaded 1.25 million shares in the IPO. As my illustrious predecessor, Alan Abelson, liked to observe, there are many good reasons to sell a stock, but expecting it to go up isn’t one of them. That has never been more true, given the ability of rich owners to monetize their assets by borrowing against them cheaply, and without incurring capital-gains taxes.</p>\n<p>To be sure, Tenev and Bhatt still have significant stakes in Robinhood. Asour colleague Avi Salzman reported, these were worth $2.5 billion at the initial offering price, and Tenev and Bhatt retain voting control. The two also could receive awards of shares worth as much as $6.7 billion for Tenev and $4 billion for Bhatt, if the stock hits $300, or nearly the proverbial ten-bagger from here.</p>\n<p>But in a blow against income inequality, the potential billionaire pair took symbolic pay cuts, to $34,248, the average annual wage of American workers. As the comedian Yakov Smirnoff likes to say, “What a country!”</p>\n<p>How those workers are faring will be a subject of the monthly employment report slated for release this coming Friday.</p>\n<p>Economists’ forecasts for nonfarm payrolls center around a gain of 900,000. Jefferies economists Aneta Markowska and Thomas Simons estimate that the increase could top the long-anticipated one million mark; they forecast 1.2 million.</p>\n<p>Markowska and Simons think the expiration of supplemental unemployment benefits in some states will boost the labor supply, although that is a matter of significant debate. (For more on the jobs market, seethis week’s cover story.)</p>\n<p></p>","source":"lsy1610680873436","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Investors, Beware! Stocks Are Entering the Most Dangerous Stretch of the Year</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nInvestors, Beware! Stocks Are Entering the Most Dangerous Stretch of the Year\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-08-01 11:07 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.barrons.com/articles/stocks-news-robinhood-sp500-51627692215?mod=hp_LATEST><strong>Barron's</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>“Yes, it’s summer, my time of year,”as the group War sangin that golden oldie “Summer” from the 1970s, recalling pleasant times at the beach or by the barbecue. No need to remind anyone back then of ...</p>\n\n<a href=\"https://www.barrons.com/articles/stocks-news-robinhood-sp500-51627692215?mod=hp_LATEST\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".IXIC":"NASDAQ Composite","SPY":"标普500ETF",".DJI":"道琼斯",".SPX":"S&P 500 Index"},"source_url":"https://www.barrons.com/articles/stocks-news-robinhood-sp500-51627692215?mod=hp_LATEST","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1142925544","content_text":"“Yes, it’s summer, my time of year,”as the group War sangin that golden oldie “Summer” from the 1970s, recalling pleasant times at the beach or by the barbecue. No need to remind anyone back then of droughts, wildfires, or Covid-19 surges that are unfortunate features of the steamy season this year.\nBut the coming of August also means entering what historically has been the most treacherous stretch of the year for stocks, according to data going back to 1928 compiled by Bank of America analyst Stephen Suttmeier. He finds that theS&P 500index had a negative return averaging 0.03% in August, September, and October—the worst three-month span of the year for the big-cap benchmark. In fact, they constitute the only three-month period that averages in the red.\nAugust actually is bracketed by the best and worst months of the year, he adds in a research note. July averages a 1.58% return on the S&P 500, with positive results 59.1% of the time, while September averages a negative 1.03%, ending in the plus column less than half of the time, or 45%.\nThis July did even better than the norm, with the S&P 500 gaining 2.27%. It also was the sixth consecutive up month for the index—the longest positive streak since September 2018, according to Dow Jones’ statistical mavens. During that period, its cumulative advance was 18.34%.\nAugust’s record is in between, with an average 0.70% S&P 500 return and positive results 58.1% of the time, marking a transition from the “summer rip” to the “fall dip.”\nNot surprisingly, the laggard returns of the August-October period are accompanied by an uptick in volatility, Suttmeier finds. Based on records going back to 1992, theCboe Volatility Index,or VIX, has often seen spikes during those months, following relatively subdued volatility in the April-July period.\nPast isn’t necessarily prologue, but if it is, the timing of the initial public offering byRobinhood Markets(ticker: HOOD) might prove propitious, if the stock market does have its typical seasonal rough patch. The online broker, whose putative mission is to open investing to novices supposedly ignored by established outfits, sold 55 million shares at $38 on Thursday. In the process, it provided a valuable lesson to all those who got in on the IPO: Buy low and sell high.\nThe company evidently fulfilled the latter imperative, selling its shares high, even though they were priced at the low end of the expected $38-$42 range. Their price sank 8.4% on their first day of trading, although they recouped a bit on Friday. By week’s end, buyers of Robinhood’s IPO who held were down 7.5%.\nAmong those who sold high were the company’s co-founders, CEO Vladimir Tenev and Chief Creative Officer Baiju Bhatt, who each offloaded 1.25 million shares in the IPO. As my illustrious predecessor, Alan Abelson, liked to observe, there are many good reasons to sell a stock, but expecting it to go up isn’t one of them. That has never been more true, given the ability of rich owners to monetize their assets by borrowing against them cheaply, and without incurring capital-gains taxes.\nTo be sure, Tenev and Bhatt still have significant stakes in Robinhood. Asour colleague Avi Salzman reported, these were worth $2.5 billion at the initial offering price, and Tenev and Bhatt retain voting control. The two also could receive awards of shares worth as much as $6.7 billion for Tenev and $4 billion for Bhatt, if the stock hits $300, or nearly the proverbial ten-bagger from here.\nBut in a blow against income inequality, the potential billionaire pair took symbolic pay cuts, to $34,248, the average annual wage of American workers. As the comedian Yakov Smirnoff likes to say, “What a country!”\nHow those workers are faring will be a subject of the monthly employment report slated for release this coming Friday.\nEconomists’ forecasts for nonfarm payrolls center around a gain of 900,000. Jefferies economists Aneta Markowska and Thomas Simons estimate that the increase could top the long-anticipated one million mark; they forecast 1.2 million.\nMarkowska and Simons think the expiration of supplemental unemployment benefits in some states will boost the labor supply, although that is a matter of significant debate. (For more on the jobs market, seethis week’s cover story.)","news_type":1,"symbols_score_info":{".DJI":0.9,".IXIC":0.9,".SPX":0.9,"SPY":0.9}},"isVote":1,"tweetType":1,"viewCount":661,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":802016420,"gmtCreate":1627698737660,"gmtModify":1633757000465,"author":{"id":"3581937708618440","authorId":"3581937708618440","name":"CEXL83","avatar":"https://static.tigerbbs.com/9f2c9405fa013dc6a212860bb07a6d46","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3581937708618440","authorIdStr":"3581937708618440"},"themes":[],"htmlText":"Hopefully next month will be a better month for all of us!","listText":"Hopefully next month will be a better month for all of us!","text":"Hopefully next month will be a better month for all of us!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":8,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/802016420","repostId":"2155001152","repostType":4,"isVote":1,"tweetType":1,"viewCount":493,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":168368697,"gmtCreate":1623951471319,"gmtModify":1634025305054,"author":{"id":"3581937708618440","authorId":"3581937708618440","name":"CEXL83","avatar":"https://static.tigerbbs.com/9f2c9405fa013dc6a212860bb07a6d46","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3581937708618440","authorIdStr":"3581937708618440"},"themes":[],"htmlText":"Like","listText":"Like","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/168368697","repostId":"2144742672","repostType":4,"isVote":1,"tweetType":1,"viewCount":946,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":168368137,"gmtCreate":1623951445329,"gmtModify":1634025305298,"author":{"id":"3581937708618440","authorId":"3581937708618440","name":"CEXL83","avatar":"https://static.tigerbbs.com/9f2c9405fa013dc6a212860bb07a6d46","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3581937708618440","authorIdStr":"3581937708618440"},"themes":[],"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/168368137","repostId":"2144426397","repostType":4,"isVote":1,"tweetType":1,"viewCount":652,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":168361534,"gmtCreate":1623951426428,"gmtModify":1634025305843,"author":{"id":"3581937708618440","authorId":"3581937708618440","name":"CEXL83","avatar":"https://static.tigerbbs.com/9f2c9405fa013dc6a212860bb07a6d46","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3581937708618440","authorIdStr":"3581937708618440"},"themes":[],"htmlText":"Can buy?","listText":"Can buy?","text":"Can buy?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/168361534","repostId":"2144690742","repostType":4,"repost":{"id":"2144690742","kind":"news","pubTimestamp":1623942044,"share":"https://ttm.financial/m/news/2144690742?lang=&edition=full","pubTime":"2021-06-17 23:00","market":"us","language":"en","title":"Column: The FDA's hasty approval of a new Alzheimer's drug is looking worse than ever","url":"https://stock-news.laohu8.com/highlight/detail?id=2144690742","media":"LA Times","summary":"The FDA's decision on Aduhelm sets up a healthcare spending crisis. \nFollowing a year in which the F","content":"<p><img src=\"https://static.tigerbbs.com/5a6526be3c93006ee9d37664f7f4650b\" tg-width=\"840\" tg-height=\"560\" referrerpolicy=\"no-referrer\">The FDA's decision on Aduhelm sets up a healthcare spending crisis.&nbsp;</p>\n<p>Following a year in which the Food and Drug Administration meekly allowed President Trump to denigrate its integrity and undermine its judgment, it wasn't clear that the agency could fall even lower in public and professional esteem.</p>\n<p>It's clear now. The FDA's widely criticized decision on June 7 to approve the new Alzheimer's drug Aduhelm despite a nearly complete absence of evidence that it works is looking worse and worse with every day that passes.</p>\n<p>The latest data point underscoring the disastrous consequences of the FDA approval is related to the sky-high average price of $56,000 a year for the drug set by its U.S. manufacturer, Biogen.</p>\n<blockquote>\n The limited evidence for the efficacy of Aduhelm raises the question of whether its large impact on health spending is justified.\n</blockquote>\n<p>Altarum consultants</p>\n<p>According to a report by the nonprofit healthcare consulting organization Altarum, if the drug is prescribed for only 1 million patients a year — the low end of Biogen's marketing expectations — by the mid-2020s it will account for more than 1% of all national health spending. In 2025, for instance, when total spending is expected to reach abut $5.3 trillion, $57 billion of that will be spent on Aduhelm.</p>\n<p>The drug will increase all prescription drug spending by 8% and non-retail drug spending — that is, for drugs that have to be administered in hospitals or doctors' offices — by 25%. If the patient caseload doubles, so will those figures. And the FDA's approval would allow Aduhelm to be prescribed for any of the nation's Alzheimer's patients, who currently number more than 6 million.</p>\n<p>That will impose higher costs on 56 million Americans enrolled in Medicare Part B even if they don't suffer from Alzheimer's, the Kaiser Family Foundation observes. That's because Medicare is required by law to cover all prescription medicines approved by the FDA. Part B premiums rise with Medicare's expenses, so the higher spending on Adulhelm will hit all premium payers in the pocketbook.</p>\n<p>If 1 million Part B members take Aduhelm, the program's 80% share of the drug's cost would come to nearly $45 billion, or well more than the $37 billion Medicare paid for all Part B drugs in 2019.</p>\n<p>Many Medicare patients taking the drug will be hard-pressed to afford it, KFF notes. Their 20%, uncapped share of Part B drug and services costs would mean an average bill of $11,200 per year for the drug. That's almost 40% of the $29,650 median income of Medicare Part B members.</p>\n<p>It gets worse. Altarum's estimates don't encompass the ancillary costs that will be associated with taking Aduhelm. Because the clinical trials revealed that about 30% of patients receiving a high dose of the drug experienced brain swelling, patients will have to undergo regular MRI tests to watch out for this dangerous side effect. They'll have to pay their share of that, too.</p>\n<p>This isn't the first time that a new drug has threatened to break the national healthcare bank. The best comparison may be the hepatitis-C drugs Sovaldi and Harvoni, which were priced by their developer, Gilead, at $84,000 and nearly $100,000 per year, respectively.</p>\n<p>Those drugs drove annual growth in retail prescription spending from 2.2% in 2013 to 13.5% in 2014, after their introduction, Altarum says.</p>\n<p>But there are differences. Sovaldi and Harvoni cured more than 90% of hepatitis-C patients after a single round of treatment, so the spending on any patient lasted less than a year; measuring their cost against the cost of treating hepatitis-C patients indefinitely made the cost-benefit balance obvious. Indeed, by 2016, when most patients had been treated, the prescription growth rate fell back to 1.7%,</p>\n<p>But Aduhelm is neither a cure nor a <a href=\"https://laohu8.com/S/AONE\">one</a>-time treatment. \"Aduhelm is to be administered repeatedly throughout the patient’s lifetime or until the patient and his or her physician elect to discontinue treatment,\" Altarum explains. \"The resultant growth in spending will therefore be sustained for the foreseeable future.\"</p>\n<p>The organization's bottom line: \"The limited evidence for the efficacy of Aduhelm raises the question of whether its large impact on health spending is justified.\"</p>\n<p>As bad as the FDA's decision is looking today, it didn't start out as a widely praised action, either. As we reported last week, <a href=\"https://laohu8.com/S/AONE.U\">one</a> member of the FDA scientific advisory committee that had examined results from the drug's clinical trials pronounced the action \"probably the worst drug approval decision in recent U.S. history” in a letter resigning from the committee.</p>\n<p>The 11-member committee had advised almost unanimously against the approval. <a href=\"https://laohu8.com/S/TWOA.U\">Two</a> other members also resigned after the FDA ignored the panel's recommendation.</p>\n<p>Alzheimer's specialists are concerned about the FDA decision for more than financial reasons. They fear that the existence of a drug with the FDA's imprimatur, as questionable as it is, will interfere with efforts to develop and test other treatments that may turn out to be more promising.</p>\n<p>Patients may be reluctant to enroll in trials of alternative drugs instead of taking Aduhelm, for example. And researchers trying to recruit trial subjects will have to reject anyone who has been treated with Aduhelm, because it will be difficult, if not impossible, to determine whether a given result is due to Aduhelm or the new drug.</p>\n<p>The longest-lasting effect, however, may be on the FDA's reputation for imposing rigorous safety and efficacy standards. The pharmaceutical industry has long groused about the agency's painstaking approval process, even though it has given the American drug market an image as the safest in the world.</p>\n<p>The drugmakers have consistently pushed for faster approvals and the acceptance of ever more sketchy evidence from clinical trials.</p>\n<p>Aaron S. Kesselheim, the Harvard professor who delivered that damning judgment about the FDA approval before resigning from its advisory panel, has called for the creation of a new agency to oversee drug approvals, presumably inoculated from pressure from Big Pharma.</p>\n<p>The FDA's approval of a high-priced, apparently low-value drug that will yield billions of dollars in profits for its manufacturer may even spur Congress finally to take America's drug-price crisis in hand and find a solution. That could be the silver lining around the cloud of the FDA's action.</p>\n<p>But it will be a shame that an agency that reigned as a bulwark against unsafe and ineffective drugs since its founding in 1906 had to fall so low to achieve that goal.</p>\n<p>This story originally appeared in Los Angeles Times.</p>","source":"yahoofinance","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Column: The FDA's hasty approval of a new Alzheimer's drug is looking worse than ever</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nColumn: The FDA's hasty approval of a new Alzheimer's drug is looking worse than ever\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-17 23:00 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/column-fdas-hasty-approval-alzheimers-144244083.html><strong>LA Times</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>The FDA's decision on Aduhelm sets up a healthcare spending crisis. \nFollowing a year in which the Food and Drug Administration meekly allowed President Trump to denigrate its integrity and undermine ...</p>\n\n<a href=\"https://finance.yahoo.com/news/column-fdas-hasty-approval-alzheimers-144244083.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"source_url":"https://finance.yahoo.com/news/column-fdas-hasty-approval-alzheimers-144244083.html","is_english":true,"share_image_url":"https://static.laohu8.com/5f26f4a48f9cb3e29be4d71d3ba8c038","article_id":"2144690742","content_text":"The FDA's decision on Aduhelm sets up a healthcare spending crisis. \nFollowing a year in which the Food and Drug Administration meekly allowed President Trump to denigrate its integrity and undermine its judgment, it wasn't clear that the agency could fall even lower in public and professional esteem.\nIt's clear now. The FDA's widely criticized decision on June 7 to approve the new Alzheimer's drug Aduhelm despite a nearly complete absence of evidence that it works is looking worse and worse with every day that passes.\nThe latest data point underscoring the disastrous consequences of the FDA approval is related to the sky-high average price of $56,000 a year for the drug set by its U.S. manufacturer, Biogen.\n\n The limited evidence for the efficacy of Aduhelm raises the question of whether its large impact on health spending is justified.\n\nAltarum consultants\nAccording to a report by the nonprofit healthcare consulting organization Altarum, if the drug is prescribed for only 1 million patients a year — the low end of Biogen's marketing expectations — by the mid-2020s it will account for more than 1% of all national health spending. In 2025, for instance, when total spending is expected to reach abut $5.3 trillion, $57 billion of that will be spent on Aduhelm.\nThe drug will increase all prescription drug spending by 8% and non-retail drug spending — that is, for drugs that have to be administered in hospitals or doctors' offices — by 25%. If the patient caseload doubles, so will those figures. And the FDA's approval would allow Aduhelm to be prescribed for any of the nation's Alzheimer's patients, who currently number more than 6 million.\nThat will impose higher costs on 56 million Americans enrolled in Medicare Part B even if they don't suffer from Alzheimer's, the Kaiser Family Foundation observes. That's because Medicare is required by law to cover all prescription medicines approved by the FDA. Part B premiums rise with Medicare's expenses, so the higher spending on Adulhelm will hit all premium payers in the pocketbook.\nIf 1 million Part B members take Aduhelm, the program's 80% share of the drug's cost would come to nearly $45 billion, or well more than the $37 billion Medicare paid for all Part B drugs in 2019.\nMany Medicare patients taking the drug will be hard-pressed to afford it, KFF notes. Their 20%, uncapped share of Part B drug and services costs would mean an average bill of $11,200 per year for the drug. That's almost 40% of the $29,650 median income of Medicare Part B members.\nIt gets worse. Altarum's estimates don't encompass the ancillary costs that will be associated with taking Aduhelm. Because the clinical trials revealed that about 30% of patients receiving a high dose of the drug experienced brain swelling, patients will have to undergo regular MRI tests to watch out for this dangerous side effect. They'll have to pay their share of that, too.\nThis isn't the first time that a new drug has threatened to break the national healthcare bank. The best comparison may be the hepatitis-C drugs Sovaldi and Harvoni, which were priced by their developer, Gilead, at $84,000 and nearly $100,000 per year, respectively.\nThose drugs drove annual growth in retail prescription spending from 2.2% in 2013 to 13.5% in 2014, after their introduction, Altarum says.\nBut there are differences. Sovaldi and Harvoni cured more than 90% of hepatitis-C patients after a single round of treatment, so the spending on any patient lasted less than a year; measuring their cost against the cost of treating hepatitis-C patients indefinitely made the cost-benefit balance obvious. Indeed, by 2016, when most patients had been treated, the prescription growth rate fell back to 1.7%,\nBut Aduhelm is neither a cure nor a one-time treatment. \"Aduhelm is to be administered repeatedly throughout the patient’s lifetime or until the patient and his or her physician elect to discontinue treatment,\" Altarum explains. \"The resultant growth in spending will therefore be sustained for the foreseeable future.\"\nThe organization's bottom line: \"The limited evidence for the efficacy of Aduhelm raises the question of whether its large impact on health spending is justified.\"\nAs bad as the FDA's decision is looking today, it didn't start out as a widely praised action, either. As we reported last week, one member of the FDA scientific advisory committee that had examined results from the drug's clinical trials pronounced the action \"probably the worst drug approval decision in recent U.S. history” in a letter resigning from the committee.\nThe 11-member committee had advised almost unanimously against the approval. Two other members also resigned after the FDA ignored the panel's recommendation.\nAlzheimer's specialists are concerned about the FDA decision for more than financial reasons. They fear that the existence of a drug with the FDA's imprimatur, as questionable as it is, will interfere with efforts to develop and test other treatments that may turn out to be more promising.\nPatients may be reluctant to enroll in trials of alternative drugs instead of taking Aduhelm, for example. And researchers trying to recruit trial subjects will have to reject anyone who has been treated with Aduhelm, because it will be difficult, if not impossible, to determine whether a given result is due to Aduhelm or the new drug.\nThe longest-lasting effect, however, may be on the FDA's reputation for imposing rigorous safety and efficacy standards. The pharmaceutical industry has long groused about the agency's painstaking approval process, even though it has given the American drug market an image as the safest in the world.\nThe drugmakers have consistently pushed for faster approvals and the acceptance of ever more sketchy evidence from clinical trials.\nAaron S. Kesselheim, the Harvard professor who delivered that damning judgment about the FDA approval before resigning from its advisory panel, has called for the creation of a new agency to oversee drug approvals, presumably inoculated from pressure from Big Pharma.\nThe FDA's approval of a high-priced, apparently low-value drug that will yield billions of dollars in profits for its manufacturer may even spur Congress finally to take America's drug-price crisis in hand and find a solution. That could be the silver lining around the cloud of the FDA's action.\nBut it will be a shame that an agency that reigned as a bulwark against unsafe and ineffective drugs since its founding in 1906 had to fall so low to achieve that goal.\nThis story originally appeared in Los Angeles Times.","news_type":1,"symbols_score_info":{"BIIB":0.9}},"isVote":1,"tweetType":1,"viewCount":856,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":168360554,"gmtCreate":1623951155778,"gmtModify":1634025307945,"author":{"id":"3581937708618440","authorId":"3581937708618440","name":"CEXL83","avatar":"https://static.tigerbbs.com/9f2c9405fa013dc6a212860bb07a6d46","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3581937708618440","authorIdStr":"3581937708618440"},"themes":[],"htmlText":"Up","listText":"Up","text":"Up","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/168360554","repostId":"1108846547","repostType":4,"repost":{"id":"1108846547","kind":"news","pubTimestamp":1623943021,"share":"https://ttm.financial/m/news/1108846547?lang=&edition=full","pubTime":"2021-06-17 23:17","market":"us","language":"en","title":"Why Bankers Just Complicated El Salvador’s Bitcoin Plan","url":"https://stock-news.laohu8.com/highlight/detail?id=1108846547","media":"investorplace","summary":"The price ofBitcoin(CCC:BTC-USD) slipped to below $39,000 on Thursday after the World Bank refused E","content":"<p>The price of<b>Bitcoin</b>(CCC:<b><u>BTC-USD</u></b>) slipped to below $39,000 on Thursday after the World Bank refused El Salvador’s request to help with the implementation of the cryptocurrency as a legal tender. The value of BTC has depreciated about 0.4% in the last 24 hours.</p>\n<p>Last week, the Latin American country’s president, Nayib Bukele, tweeted a reveal of his El Salvador Bitcoin plan :</p>\n<p>He deflected concerns about the cryptocurrency’s environmental impact with another tweet that indicated the country would use clean energy for mining:</p>\n<blockquote>\n “Our engineers just informed me that they dug a new well, that will provide approximately 95MW of 100% clean, 0 emissions geothermal energy from our volcanosStarting to design a full#Bitcoinmining hub around it.”\n</blockquote>\n<p>Yet that wasn’t enough to prevent theWorld Bank crypto kibosh. The lender said it could not assist El Salvador’s Bitcoin plan due to the environmental impact of mining and transparency challenges. “We are committed to helping El Salvador in numerous ways including for currency transparency and regulatory processes,” a spokesperson for the international lender told<i>Reuters</i>.</p>\n<p>“While the government did approach us for assistance on Bitcoin, this is not something the World Bank can support given the environmental and transparency shortcomings.”</p>\n<p>El Salvador Bitcoin Plan Would Be a First</p>\n<p>El Salvador is looking to offermore financial freedomto citizens who might not have access to traditional financial services. That makes sense as&nbsp;only 30% of citizens have access to such services. Folks there won’t have to use a government wallet to hold BTC. And while all businesses will have to accept Bitcoin, they won’t necessarily have to hold onto it.</p>\n<p>What else is inthe El Salvador Bitcoin plan, which makes the country the first in the world to accept the cryptocurrency as legal tender?</p>\n<ul>\n <li>The government is setting up a fund that will allow businesses to exchange BTC for U.S. dollars.</li>\n <li>This fund will hold $150 million and will regularly sell Bitcoin to replenish its resources.</li>\n <li>In addition to all of this, Bukele also revealed that investing in the economy of El Salvador can grant a person citizenship.</li>\n <li>He said that anyone that invests 3 BTC, or about $117,0000 as of this writing, into the economy will obtain citizenship in the country.</li>\n</ul>","source":"lsy1606302653667","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Why Bankers Just Complicated El Salvador’s Bitcoin Plan</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWhy Bankers Just Complicated El Salvador’s Bitcoin Plan\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-17 23:17 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://investorplace.com/2021/06/world-bank-crypto-news-why-bankers-just-complicated-el-salvadors-bitcoin-plan/><strong>investorplace</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>The price ofBitcoin(CCC:BTC-USD) slipped to below $39,000 on Thursday after the World Bank refused El Salvador’s request to help with the implementation of the cryptocurrency as a legal tender. The ...</p>\n\n<a href=\"https://investorplace.com/2021/06/world-bank-crypto-news-why-bankers-just-complicated-el-salvadors-bitcoin-plan/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"GBTC":"Grayscale Bitcoin Trust ETF"},"source_url":"https://investorplace.com/2021/06/world-bank-crypto-news-why-bankers-just-complicated-el-salvadors-bitcoin-plan/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1108846547","content_text":"The price ofBitcoin(CCC:BTC-USD) slipped to below $39,000 on Thursday after the World Bank refused El Salvador’s request to help with the implementation of the cryptocurrency as a legal tender. The value of BTC has depreciated about 0.4% in the last 24 hours.\nLast week, the Latin American country’s president, Nayib Bukele, tweeted a reveal of his El Salvador Bitcoin plan :\nHe deflected concerns about the cryptocurrency’s environmental impact with another tweet that indicated the country would use clean energy for mining:\n\n “Our engineers just informed me that they dug a new well, that will provide approximately 95MW of 100% clean, 0 emissions geothermal energy from our volcanosStarting to design a full#Bitcoinmining hub around it.”\n\nYet that wasn’t enough to prevent theWorld Bank crypto kibosh. The lender said it could not assist El Salvador’s Bitcoin plan due to the environmental impact of mining and transparency challenges. “We are committed to helping El Salvador in numerous ways including for currency transparency and regulatory processes,” a spokesperson for the international lender toldReuters.\n“While the government did approach us for assistance on Bitcoin, this is not something the World Bank can support given the environmental and transparency shortcomings.”\nEl Salvador Bitcoin Plan Would Be a First\nEl Salvador is looking to offermore financial freedomto citizens who might not have access to traditional financial services. That makes sense as only 30% of citizens have access to such services. Folks there won’t have to use a government wallet to hold BTC. And while all businesses will have to accept Bitcoin, they won’t necessarily have to hold onto it.\nWhat else is inthe El Salvador Bitcoin plan, which makes the country the first in the world to accept the cryptocurrency as legal tender?\n\nThe government is setting up a fund that will allow businesses to exchange BTC for U.S. dollars.\nThis fund will hold $150 million and will regularly sell Bitcoin to replenish its resources.\nIn addition to all of this, Bukele also revealed that investing in the economy of El Salvador can grant a person citizenship.\nHe said that anyone that invests 3 BTC, or about $117,0000 as of this writing, into the economy will obtain citizenship in the country.","news_type":1,"symbols_score_info":{"GBTC":0.9}},"isVote":1,"tweetType":1,"viewCount":1354,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":168962803,"gmtCreate":1623947124002,"gmtModify":1634025388589,"author":{"id":"3581937708618440","authorId":"3581937708618440","name":"CEXL83","avatar":"https://static.tigerbbs.com/9f2c9405fa013dc6a212860bb07a6d46","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3581937708618440","authorIdStr":"3581937708618440"},"themes":[],"htmlText":"Can buy?","listText":"Can buy?","text":"Can buy?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/168962803","repostId":"1100514296","repostType":4,"repost":{"id":"1100514296","kind":"news","pubTimestamp":1623943229,"share":"https://ttm.financial/m/news/1100514296?lang=&edition=full","pubTime":"2021-06-17 23:20","market":"us","language":"en","title":"RUN Stock: Why Morgan Stanley Thinks Sunrun Is the ‘Most Compelling’ Clean Energy Stock","url":"https://stock-news.laohu8.com/highlight/detail?id=1100514296","media":"investorplace","summary":"Sunrun(NASDAQ:RUN) stock is running higher on Thursday following a positive report on the company fr","content":"<p><b>Sunrun</b>(NASDAQ:<b><u>RUN</u></b>) stock is running higher on Thursday following a positive report on the company from Morgan Stanley.</p>\n<p>Morgan Stanley analyst Stephen Byrd isbehind the newsboosting RUN stock up. In his report, he reiterated the firm’s overweight rating while also increasing the price target to $91. The previous price target MS had for the stock was $86.</p>\n<p>So what has Byrd taking such a bullish stance on RUN stock? First off, he believes that there’s massive potential for the growth of the company. That centers on the adoption of solar panels to power homes. Currently, only 3% of homes in the U.S. are equipped with solar panels.</p>\n<p>It’s not just the potential of solar homes that has the Morgan Stanley analyst taking this stance on RUN stock. The possibility of its technology being used alongside electric vehicles (EVs) also shows promise.</p>\n<p>Sunrun has already been dipping its toes into this space as it teams up with<b>Ford</b>(NYSE:<b><u>F</u></b>) on the company’sF-150 Lightning electric truck. It supplies solar panels to charge the truck at home, as well as a kit that lets the truck power the house when the electricity is out. These factors are what has Byrd calling RUN “the most compelling clean energy stock,” reports<i>CNBC</i>.</p>\n<p>The bull report on RUN stock has it seeing heavy trading today. As of this writing, more than 10 million shares of the stock have changed hands. To put that in perspective, the company’s daily average trading volume is roughly 6.2 million shares.</p>\n<p>RUN stock was up 10.2% as of Thursday morning but is down 24.5% since the start of the year.</p>\n<p>Of course, there’s plenty of other news for today that investors should keep up with.</p>","source":"lsy1606302653667","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>RUN Stock: Why Morgan Stanley Thinks Sunrun Is the ‘Most Compelling’ Clean Energy Stock</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nRUN Stock: Why Morgan Stanley Thinks Sunrun Is the ‘Most Compelling’ Clean Energy Stock\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-17 23:20 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://investorplace.com/2021/06/run-stock-why-morgan-stanley-thinks-sunrun-is-the-most-compelling-clean-energy-stock/><strong>investorplace</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Sunrun(NASDAQ:RUN) stock is running higher on Thursday following a positive report on the company from Morgan Stanley.\nMorgan Stanley analyst Stephen Byrd isbehind the newsboosting RUN stock up. In ...</p>\n\n<a href=\"https://investorplace.com/2021/06/run-stock-why-morgan-stanley-thinks-sunrun-is-the-most-compelling-clean-energy-stock/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"source_url":"https://investorplace.com/2021/06/run-stock-why-morgan-stanley-thinks-sunrun-is-the-most-compelling-clean-energy-stock/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1100514296","content_text":"Sunrun(NASDAQ:RUN) stock is running higher on Thursday following a positive report on the company from Morgan Stanley.\nMorgan Stanley analyst Stephen Byrd isbehind the newsboosting RUN stock up. In his report, he reiterated the firm’s overweight rating while also increasing the price target to $91. The previous price target MS had for the stock was $86.\nSo what has Byrd taking such a bullish stance on RUN stock? First off, he believes that there’s massive potential for the growth of the company. That centers on the adoption of solar panels to power homes. Currently, only 3% of homes in the U.S. are equipped with solar panels.\nIt’s not just the potential of solar homes that has the Morgan Stanley analyst taking this stance on RUN stock. The possibility of its technology being used alongside electric vehicles (EVs) also shows promise.\nSunrun has already been dipping its toes into this space as it teams up withFord(NYSE:F) on the company’sF-150 Lightning electric truck. It supplies solar panels to charge the truck at home, as well as a kit that lets the truck power the house when the electricity is out. These factors are what has Byrd calling RUN “the most compelling clean energy stock,” reportsCNBC.\nThe bull report on RUN stock has it seeing heavy trading today. As of this writing, more than 10 million shares of the stock have changed hands. To put that in perspective, the company’s daily average trading volume is roughly 6.2 million shares.\nRUN stock was up 10.2% as of Thursday morning but is down 24.5% since the start of the year.\nOf course, there’s plenty of other news for today that investors should keep up with.","news_type":1,"symbols_score_info":{"RUN":0.9}},"isVote":1,"tweetType":1,"viewCount":1181,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":168966650,"gmtCreate":1623947106070,"gmtModify":1634025389388,"author":{"id":"3581937708618440","authorId":"3581937708618440","name":"CEXL83","avatar":"https://static.tigerbbs.com/9f2c9405fa013dc6a212860bb07a6d46","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3581937708618440","authorIdStr":"3581937708618440"},"themes":[],"htmlText":"Up","listText":"Up","text":"Up","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/168966650","repostId":"1108846547","repostType":4,"repost":{"id":"1108846547","kind":"news","pubTimestamp":1623943021,"share":"https://ttm.financial/m/news/1108846547?lang=&edition=full","pubTime":"2021-06-17 23:17","market":"us","language":"en","title":"Why Bankers Just Complicated El Salvador’s Bitcoin Plan","url":"https://stock-news.laohu8.com/highlight/detail?id=1108846547","media":"investorplace","summary":"The price ofBitcoin(CCC:BTC-USD) slipped to below $39,000 on Thursday after the World Bank refused E","content":"<p>The price of<b>Bitcoin</b>(CCC:<b><u>BTC-USD</u></b>) slipped to below $39,000 on Thursday after the World Bank refused El Salvador’s request to help with the implementation of the cryptocurrency as a legal tender. The value of BTC has depreciated about 0.4% in the last 24 hours.</p>\n<p>Last week, the Latin American country’s president, Nayib Bukele, tweeted a reveal of his El Salvador Bitcoin plan :</p>\n<p>He deflected concerns about the cryptocurrency’s environmental impact with another tweet that indicated the country would use clean energy for mining:</p>\n<blockquote>\n “Our engineers just informed me that they dug a new well, that will provide approximately 95MW of 100% clean, 0 emissions geothermal energy from our volcanosStarting to design a full#Bitcoinmining hub around it.”\n</blockquote>\n<p>Yet that wasn’t enough to prevent theWorld Bank crypto kibosh. The lender said it could not assist El Salvador’s Bitcoin plan due to the environmental impact of mining and transparency challenges. “We are committed to helping El Salvador in numerous ways including for currency transparency and regulatory processes,” a spokesperson for the international lender told<i>Reuters</i>.</p>\n<p>“While the government did approach us for assistance on Bitcoin, this is not something the World Bank can support given the environmental and transparency shortcomings.”</p>\n<p>El Salvador Bitcoin Plan Would Be a First</p>\n<p>El Salvador is looking to offermore financial freedomto citizens who might not have access to traditional financial services. That makes sense as&nbsp;only 30% of citizens have access to such services. Folks there won’t have to use a government wallet to hold BTC. And while all businesses will have to accept Bitcoin, they won’t necessarily have to hold onto it.</p>\n<p>What else is inthe El Salvador Bitcoin plan, which makes the country the first in the world to accept the cryptocurrency as legal tender?</p>\n<ul>\n <li>The government is setting up a fund that will allow businesses to exchange BTC for U.S. dollars.</li>\n <li>This fund will hold $150 million and will regularly sell Bitcoin to replenish its resources.</li>\n <li>In addition to all of this, Bukele also revealed that investing in the economy of El Salvador can grant a person citizenship.</li>\n <li>He said that anyone that invests 3 BTC, or about $117,0000 as of this writing, into the economy will obtain citizenship in the country.</li>\n</ul>","source":"lsy1606302653667","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Why Bankers Just Complicated El Salvador’s Bitcoin Plan</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWhy Bankers Just Complicated El Salvador’s Bitcoin Plan\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-17 23:17 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://investorplace.com/2021/06/world-bank-crypto-news-why-bankers-just-complicated-el-salvadors-bitcoin-plan/><strong>investorplace</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>The price ofBitcoin(CCC:BTC-USD) slipped to below $39,000 on Thursday after the World Bank refused El Salvador’s request to help with the implementation of the cryptocurrency as a legal tender. The ...</p>\n\n<a href=\"https://investorplace.com/2021/06/world-bank-crypto-news-why-bankers-just-complicated-el-salvadors-bitcoin-plan/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"GBTC":"Grayscale Bitcoin Trust ETF"},"source_url":"https://investorplace.com/2021/06/world-bank-crypto-news-why-bankers-just-complicated-el-salvadors-bitcoin-plan/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1108846547","content_text":"The price ofBitcoin(CCC:BTC-USD) slipped to below $39,000 on Thursday after the World Bank refused El Salvador’s request to help with the implementation of the cryptocurrency as a legal tender. The value of BTC has depreciated about 0.4% in the last 24 hours.\nLast week, the Latin American country’s president, Nayib Bukele, tweeted a reveal of his El Salvador Bitcoin plan :\nHe deflected concerns about the cryptocurrency’s environmental impact with another tweet that indicated the country would use clean energy for mining:\n\n “Our engineers just informed me that they dug a new well, that will provide approximately 95MW of 100% clean, 0 emissions geothermal energy from our volcanosStarting to design a full#Bitcoinmining hub around it.”\n\nYet that wasn’t enough to prevent theWorld Bank crypto kibosh. The lender said it could not assist El Salvador’s Bitcoin plan due to the environmental impact of mining and transparency challenges. “We are committed to helping El Salvador in numerous ways including for currency transparency and regulatory processes,” a spokesperson for the international lender toldReuters.\n“While the government did approach us for assistance on Bitcoin, this is not something the World Bank can support given the environmental and transparency shortcomings.”\nEl Salvador Bitcoin Plan Would Be a First\nEl Salvador is looking to offermore financial freedomto citizens who might not have access to traditional financial services. That makes sense as only 30% of citizens have access to such services. Folks there won’t have to use a government wallet to hold BTC. And while all businesses will have to accept Bitcoin, they won’t necessarily have to hold onto it.\nWhat else is inthe El Salvador Bitcoin plan, which makes the country the first in the world to accept the cryptocurrency as legal tender?\n\nThe government is setting up a fund that will allow businesses to exchange BTC for U.S. dollars.\nThis fund will hold $150 million and will regularly sell Bitcoin to replenish its resources.\nIn addition to all of this, Bukele also revealed that investing in the economy of El Salvador can grant a person citizenship.\nHe said that anyone that invests 3 BTC, or about $117,0000 as of this writing, into the economy will obtain citizenship in the country.","news_type":1,"symbols_score_info":{"GBTC":0.9}},"isVote":1,"tweetType":1,"viewCount":729,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"defaultTab":"posts","isTTM":false}